Skip to content

PTHS - Pelthos Therapeutics Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchP

Pelthos Therapeutics Inc.

PTHS · AMEX

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

P

PTHSPelthos Therapeutics Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $37.50
52-wk low: $18.19
Prev close: $32.26
Mkt cap: $98.9M
Beta: 3.13
P/S: 2.3x

Smart money

3 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

3 holders

Combined position$853K

CI
Citadel
Ken Griffin · Q2 2026 13F
$425K
position
SS
State Street

Earnings

Reported May 14, 2026

Earnings came in 30.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -199.5%
Market cap: $99M

Valuation

P/S2.28
P/B2.86

Quality

Operating margin-111.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: PTHS
Exchange: AMEX
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $98.85M
Beta: 3.13

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.9x

Profit margin

-199.5%

Op margin

-111.0%

ROE

-333.8%

Q2 2026 13F

$277K

position

BR

BlackRock

Q2 2026 13F

$150K

position

Coverage gaps for PTHS

No recent Congress trade
No recent market-voice mention

Earnings per share

-$4.66-30.2%

-$3.58 expected

Next report

What the street expects next

EPS expected

-$3.34

-$4.60 to -$1.60

Revenue expected

$18.0M

7 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

1.45

Change in 30 days

-333.8%

ROA-51.3%

Growth

Beta3.13